Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SAfiledCriticalRoussel Uclaf SA
Priority to AU16098/70ApriorityCriticalpatent/AU421074B2/en
Publication of AU1609870ApublicationCriticalpatent/AU1609870A/en
Application grantedgrantedCritical
Publication of AU421074B2publicationCriticalpatent/AU421074B2/en
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C07J1/0051—Estrane derivatives
C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
AU16098/70A1970-06-091970-06-0916-hydroxymethylene-17-oxo-^1,3,5 [10] steroids and their preparation
ExpiredAU421074B2
(en)